» Articles » PMID: 28428633

Inhibition of Glutathione Metabolism Attenuates Esophageal Cancer Progression

Overview
Journal Exp Mol Med
Date 2017 Apr 22
PMID 28428633
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Esophageal squamous cell carcinoma (ESCC) is a deadly malignancy with regard to mortality and prognosis, and the 5-year survival rate for all patients diagnosed with ESCC remains poor. A better understanding of the biological mechanisms of ESCC tumorigenesis and progression is of great importance to improve treatment of this disease. In this study, we demonstrated that the glutathione metabolism pathway is highly enriched in ESCC cells compared with normal esophageal epithelial cells in an in vivo mouse model. In addition, treatment with L-buthionine-sulfoximine (BSO) to deplete glutathione decreased the ESCC tumor burden in mice, thus demonstrating the critical role of glutathione metabolism in ESCC progression. BSO treatment also led to decreased cell proliferation and activation of cell apoptosis in ESCC. Finally, BSO treatment blocked NF-kB pathway activation in ESCC. Our study reveals a new pathway that regulates ESCC progression and suggests that inhibition of glutathione metabolism may be a potential strategy for ESCC treatment.

Citing Articles

Interplay of Cellular Nrf2/NF-κB Signalling after Plasma Stimulation of Malignant vs. Non-Malignant Dermal Cells.

Manzhula K, Rebl A, Budde-Sagert K, Rebl H Int J Mol Sci. 2024; 25(20).

PMID: 39456749 PMC: 11507371. DOI: 10.3390/ijms252010967.


Lymph node metastasis determined miRNAs in esophageal squamous cell carcinoma.

Wei F, Bi S, Li M, Yu J Aging (Albany NY). 2024; 16(20):13104-13116.

PMID: 39401765 PMC: 11552642. DOI: 10.18632/aging.206122.


Study on the Mechanism of FOXA2 Activation on Glutathione Metabolic Reprogramming Mediated by ETV4 Transcription to Facilitate Colorectal Cancer Malignant Progression.

Zhang X, He Y, Shen J, Zhou B, Qin H, Zhang S Biochem Genet. 2024; .

PMID: 39316306 DOI: 10.1007/s10528-024-10918-y.


DMMIC derivatization-assisted liquid chromatography-mass spectrometry method for metabolite profiling of the glutathione anabolic pathway in esophageal cancer tissues and cells.

Liu L, Lu Y, Wang M, Zhao Q, Chen X, Yin H J Pharm Anal. 2024; 13(11):1365-1373.

PMID: 38174115 PMC: 10759256. DOI: 10.1016/j.jpha.2023.08.016.


Unraveling the Complexity of Regulated Cell Death in Esophageal Cancer: from Underlying Mechanisms to Targeted Therapeutics.

Zhang H, Zhang J, Luan S, Liu Z, Li X, Liu B Int J Biol Sci. 2023; 19(12):3831-3868.

PMID: 37564206 PMC: 10411468. DOI: 10.7150/ijbs.85753.


References
1.
Liao B, Hsieh C, Lin Y, Wung B . The glutaredoxin/glutathione system modulates NF-kappaB activity by glutathionylation of p65 in cinnamaldehyde-treated endothelial cells. Toxicol Sci. 2010; 116(1):151-63. DOI: 10.1093/toxsci/kfq098. View

2.
Peng L, Hu Y, Chen D, Jiao S, Sun S . Ubiquitin specific peptidase 21 regulates interleukin-8 expression, stem-cell like property of human renal cell carcinoma. Oncotarget. 2016; 7(27):42007-42016. PMC: 5173112. DOI: 10.18632/oncotarget.9751. View

3.
Peng L, Song Z, Chen D, LingHu R, Wang Y, Zhang X . GINS2 regulates matrix metallopeptidase 9 expression and cancer stem cell property in human triple negative Breast cancer. Biomed Pharmacother. 2016; 84:1568-1574. DOI: 10.1016/j.biopha.2016.10.032. View

4.
Chen D, Jarrell A, Guo C, Lang R, Atit R . Dermal β-catenin activity in response to epidermal Wnt ligands is required for fibroblast proliferation and hair follicle initiation. Development. 2012; 139(8):1522-33. PMC: 3308184. DOI: 10.1242/dev.076463. View

5.
Estrela J, Ortega A, Obrador E . Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci. 2006; 43(2):143-81. DOI: 10.1080/10408360500523878. View